A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies.
Publication
, Journal Article
Kurtzberg, J; Ernst, TJ; Keating, MJ; Gandhi, V; Hodge, JP; Kisor, DF; Therriault, R; Stephens, C; Levin, J; Krenitsky, T; Elion, GB; Mitchell, BS
Published in: BLOOD
November 15, 1999
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 15, 1999
Volume
94
Issue
10
Start / End Page
629A / 629A
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kurtzberg, J., Ernst, T. J., Keating, M. J., Gandhi, V., Hodge, J. P., Kisor, D. F., … Mitchell, B. S. (1999). A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies. BLOOD, 94(10), 629A-629A.
Kurtzberg, J., T. J. Ernst, M. J. Keating, V. Gandhi, J. P. Hodge, D. F. Kisor, R. Therriault, et al. “A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies.” BLOOD 94, no. 10 (November 15, 1999): 629A-629A.
Kurtzberg J, Ernst TJ, Keating MJ, Gandhi V, Hodge JP, Kisor DF, et al. A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies. BLOOD. 1999 Nov 15;94(10):629A-629A.
Kurtzberg, J., et al. “A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies.” BLOOD, vol. 94, no. 10, AMER SOC HEMATOLOGY, Nov. 1999, pp. 629A-629A.
Kurtzberg J, Ernst TJ, Keating MJ, Gandhi V, Hodge JP, Kisor DF, Therriault R, Stephens C, Levin J, Krenitsky T, Elion GB, Mitchell BS. A Phase I study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) administered on a consecutive five day schedule in children and adults with refractory hematologic malignancies. BLOOD. AMER SOC HEMATOLOGY; 1999 Nov 15;94(10):629A-629A.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 15, 1999
Volume
94
Issue
10
Start / End Page
629A / 629A
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology